Ghana will produce its own cholera vaccine
Africa still has a high mortality rate; many people suffer from curable illnesses like cholera and diarrhea. International cooperation organizations have long spent significant funds to purchase medications for distribution to the world's poorest nations, but this strategy has drawn criticism from a number of observers who claim that pharmaceutical companies in developed nations sell their products at prices that are too high for many African nations to afford.
But even amid this bleak image, there is hope: for the past few years, some African nations have begun manufacturing the medicines and vaccines they require, lessening their reliance on Western pharmaceutical conglomerates. This may be seen in Ghana, where vaccine manufacturing for cholera and other illnesses like malaria or pneumonia has just recently started.
The most intriguing part of this story is that Ghanaian pharmaceutical firms, including Danadams, Ernest Chemists, and Kinapharna, have formed a cooperative called DEK Vaccines Limited to create these vaccines rather than a Chinese or Western firm. In two years, vaccine manufacturing is anticipated to start. The group wants to generate 600 million doses annually, including those for many additional ailments. As well as covering Ghana, the goal is to export the medications to other African nations.
The establishment of this collaboration is a component of a larger strategy devised by many African nations with the objective of increasing vaccine production in Africa from its present level of 1% to 60% by the year 2040. Naturally, the issue of paying for patent rights to those who developed the vaccines arises when vaccines are produced. In this regard, pharmaceutical industries have obtained the transfer of these production rights by signing an agreement with IVI, a non-profit organization that deals with transferring patents to produce medicines and vaccines to developing countries. This is an excellent example of how to assist Africans in their respective countries.
The more such tech is decentralized the better. Nothing has greater potential for harm to humanity than centralization of medical expertise in hands that have so often shown so much propensity to be deliberately harmful to profit more. When Ghana, and other countries, can make themselves the medicines they need, they are no longer liable to such harm from foreign entities that care more about their profits than the live of the people of Ghana.
Thanks!
Exactly, just look at Pfizer, they would abuse their knowledge and expertise for profits